Creative Planning
DAWN

Creative Planning’s Day One Biopharmaceuticals DAWN Stock Holding History

Creative Planning’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$685K Buy
31,931
+6,638
+26% +$93.5K ﹤0.01% 2775
2025
Q4 		$236K Sell
25,293
-903
-3% -$7.54K ﹤0.01% 3423
2025
Q3 		$185K Buy
26,196
+7,689
+42% +$52.9K ﹤0.01% 3520
2025
Q2 		$120K Buy
+18,507
New +$127K ﹤0.01% 3387

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Creative Planning's DAWN Position: Q1 2026 in Review

Creative Planning increased its Day One Biopharmaceuticals (DAWN) stake by 26% in Q1 2026, buying an estimated $93.5K and bringing the position to 31,931 shares worth $685K. The position accounts for ﹤0.01% of the portfolio, ranked #2775.

Creative Planning first reported a position in DAWN in Q2 2025 and has held it in 4 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Creative Planning held 31,931 shares of Day One Biopharmaceuticals worth $685K as of Q1 2026.
  • Creative Planning bought 6,638 Day One Biopharmaceuticals shares in Q1 2026, an estimated $93.5K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2775 holding.
  • Creative Planning first reported a position in Day One Biopharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.